Reactions 1704, p193 - 2 Jun 2018 Cutaneous metastatic melanoma: case report A 67-year-old man developed cutaneous metastatic melanoma following treatment with imiquimod [dosage, time to reaction onset and outcome not stated]. The man presented with a two months history of multiple cutaneous deposits, which appeared shortly following application of imiquimod for presumed actinic keratoses to the forearms. Examination revealed a widespread eruption of dark brown, purpuric papules scattered over the trunk, face and lower limbs. Later, he was diagnosed with metastatic melanoma with a positive BRAF V600E mutation. Positron emission tomography scan revealed no definitive visceral metastasis or primary cutaneous melanoma. Author comment: "Paradoxically, there are emerging case reports of the development of keratoacanthomas and infiltrating squamous cell carcinoma at sites of previous imiquimod application." "To our knowledge, this is the first reported case of de novo cutaneous melanoma metastases following imiquimod application." Schauer A, et al. Fighting fire with fire: Cutaneous melanoma metastases following imiquimod use. Australasian Journal of Dermatology 59 (Suppl. 1): 103, May 2018. Available from: URL: http://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323573 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera